SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S 1987 Genetic determinants of bone mass in adults: A twin study. J Clin Invest 80:706710.
  • 2
    Howard MH, Nguyen TV, Harris M, Kelly PJ, Eisman JA 1998 Genetic and environmental contributions to the association between quantitative ultrasound and bone mineral density measurements: A twin study. J Bone Miner Res 13:13181327.
  • 3
    Guéguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G 1995 Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 10:20172022.
  • 4
    Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA 1994 Prediction of bone density from vitamin D receptor alleles. Nature 367:284287.
  • 5
    Kröger H, Mahonen A, Ryhänen S, Turunen AM, Alhava E, Mäenpää P 1995 Vitamin D receptor genotypes and bone mineral density. Lancet 345:423424.
  • 6
    Sano M, Inoue S, Hosoi T, Ouchi Y, Emi M, Shiraki M, Orimo H 1995 Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 217:378383.
  • 7
    Han KO, Moon IG, Choi JT, Kim SW, Yoon HK, Min HK, Han IK 1997 Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. J Clin Endocrinol Metab 82:991995.
  • 8
    Willing M, Sowers M, Aron D, Clark MK, Burns T, Bunten C, Crutchfield M, D'Agostino D, Jannausch M 1998 Bone mineral density and its change in white women: Estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 13:695705.
  • 9
    Deng H-W, Li J, Li J-L, Johnson M, Gong G, Davis KM, Recker RR 1998 Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes. Hum Genet 103:576585.
  • 10
    Han K, Choi J, Moon I, Yoon H, Han I, Min H, Kim Y, Choi Y 1999 Non-association of estrogen receptor genotypes with bone mineral density and bone turnover in Korean pre-, peri-, and postmenopausal women. Osteoporos Int 9:290295.
  • 11
    Salmén T, Heikkinen A-M, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Mäenpää PH 2000 Early postmenopausal bone loss is associated with Pvu II estrogen receptor gene polymorphism in Finnish women: Effect of hormone replacement therapy. J Bone Miner Res 15:315321.
  • 12
    Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH 1996 Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet 14:203205.
  • 13
    Uitterlinden AG, Burger H, Huang Q, Yue F, McGuigan FE, Grant SF, Hofman A, van Leeuwen JP, Pols HA, Ralston SH 1998 Relation of alleles of the collagen type I alpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 338:10161021.
  • 14
    Keen RW, Woodford-Richens KL, Grant SF, Ralston SH, Lanchbury JS, Spector TD 1999 Association of polymorphism at the type I collagen (COL1A1) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnover. Arthritis Rheum 42:285290.
  • 15
    Shiraki M, Shiraki Y, Aoki C, Hosoi T, Inoue S, Kaneki M, Ouchi Y 1997 Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 12:14381445.
  • 16
    Taboulet J, Frenkian M, Frendo JL, Feingold N, Jullienne A, de Vernejoul MC 1998 Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women. Hum Mol Genet 7:21292133.
  • 17
    Houston LA, Grant SF, Reid DM, Ralston SH 1996 Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: Studies in a UK population. Bone 18:249252.
  • 18
    Gennari L, Becherini L, Mansani R, Masi L, Falchetti A, Morelli A, Colli E, Gonnelli S, Cepollaro C, Brandi ML 1999 FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women. J Bone Miner Res 14:13791386.
  • 19
    Kohlmeier M, Saupe J, Schaefer K, Asmus G 1998 Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype. Calcif Tissue Int 62:278281.
  • 20
    Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC 1976 Long-term prevention of postmenopausal osteoporosis by oestrogen: Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1:10381041.
  • 21
    Riggs BL, Melton LJ III 1986 Involutional osteoporosis. N Engl J Med 14:16761686.
  • 22
    Komulainen M, Kröger H, Tuppurainen MT, Heikkinen A-M, Alhava E, Honkanen R, Jurvelin J, Saarikoski S 1999 Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: A population-based 5-year randomized trial. J Clin Endocrinol Metab 84:546552.
  • 23
    Lufkin EG, Wahner HW, O'Fallon WM, Hodgson SF, Kotowicz MA, Lane AW, Judd HL, Caplan RH, Riggs BL 1992 Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 117:19.
  • 24
    Komulainen M, Kröger H, Tuppurainen MT, Heikkinen A-M, Alhava E, Honkanen R, Saarikoski S 1998 HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women: A 5 year randomized trial. Maturitas 31:4554.
  • 25
    Christiansen C, Riis BJ, Rodbro P 1987 Prediction of rapid bone loss in postmenopausal women. Lancet 1:11051108.
  • 26
    Hansen MA, Overgaard K, Riis BJ, Christiansen C 1991 Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ 303:961964.
  • 27
    Tuppurainen M, Honkanen R, Kröger H, Saarikoski S, Alhava E 1993 Osteoporosis risk factors, gynecological history and fractures in perimenopausal women—the results of the baseline postal inquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas 17:89100.
  • 28
    Komulainen M, Tuppurainen MT, Kröger H, Heikkinen A-M, Puntila E, Alhava E, Honkanen R, Saarikoski S 1997 Vitamin D and HRT: No benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized, placebo-controlled study. Osteoporos Int 7:126132.
  • 29
    Heikkinen A-M, Parviainen M, Niskanen L, Komulainen M, Tuppurainen M, Kröger H, Saarikoksi S 1997 Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3—a prospective, controlled, randomized study. J Clin Endocrinol Metab 82:24762482.
  • 30
    Castagnoli A, Mastri I, Bernardi F, Del Senno L 1987 PvuII RFLP inside the human estrogen receptor gene. Nucleic Acids Res 15:866.
  • 31
    Korach KS 1994 Insights from the study of animals lacking functional estrogen receptor. Science 266:15241527.
  • 32
    Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen receptor gene in a man. N Engl J Med 331:10561061.
  • 33
    Mizunuma H, Hosoi T, Okano H, Soda M, Tokizawa T, Kagami I, Miyamoto S, Ibuki Y, Inoue S, Shiraki M, Ouchi Y 1997 Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women. Bone 21:379383.
  • 34
    Kurabayashi T, Tomita M, Matsushita H, Yahata T, Honda A, Takakuwa K, Tanaka K 1999 Association of vitamin D and estrogen receptor gene polymorphism with the effect of hormone replacement therapy on bone mineral density in Japanese women. Am J Obstet Gynecol 180:11151120.
  • 35
    Hassager C, Jensen SB, Christiansen C 1994 Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss; do they exist? Osteoporos Int 4:3641.
  • 36
    Komulainen M, Kröger H, Tuppurainen MT, Heikkinen A-M, Honkanen R, Saarikoski S 2000 Identification of early postmenopausal women with no bone response to HRT: Results of a 5-year clinical trial. Osteoporos Int 11:211218.
  • 37
    Menasce LP, White GR, Harrison CJ, Boyle JM 1993 Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 17:263265.
  • 38
    Hahn GV, Cohen RB, Wozney JM, Levitz CL, Shore EM, Zasloff MA, Kaplan FS 1992 A bone morphogenetic protein subfamily: Chromosomal localization of human genes for BMP5, BMP6, and BMP7. Genomics 14:759762.
  • 39
    Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, Delmas PD, Pouilles JM, Breart G, Meunier PJ 1996 Ultrasonographic heel measurements to predict hip fracture in elderly women: The EPIDOS prospective study. Lancet 348:511514.
  • 40
    Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD 1996 Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study. J Bone Miner Res 11:15311538.
  • 41
    Heikkinen A, Parviainen MT, Tuppurainen MT, Niskanen L, Komulainen MH, Saarikoski S 1998 Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. Calcif Tissue Int 62:2630.